Covid-19 and the Cardiovascular System: From Basic Mechanisms to Clinical Perspectives – Jan 27th, 2021 (3-5 pm CET)
Cardiovascular disease as a risk factor and complication of COVID-19 – Rhian Touyz, Glasgow, UK
Covid-19, an endothelial disease – Thomas Lüscher, Zürich, Switzerland
Round Table -New Evidences and Possible Treatment Options Targeting Cardiovascular System
- Covid 19 and vascular aging – Rosa M Bruno, Paris, France
- Covid-19 and ACE2- RAAS Inhibition – Matthias Barton, Zürich, Switzerland
- Covid 19 and eicosanoids – omega-3 derived pro-resolving lipid mediators – Gokce Topal, Istanbul, Turkey
